File:An overview of epithelial–mesenchymal plasticity causes and consequences.png
From Wikimedia Commons, the free media repository
Jump to navigation
Jump to search
Size of this preview: 800 × 590 pixels. Other resolutions: 320 × 236 pixels | 640 × 472 pixels | 1,024 × 756 pixels | 1,280 × 945 pixels | 2,560 × 1,889 pixels | 2,790 × 2,059 pixels.
Original file (2,790 × 2,059 pixels, file size: 913 KB, MIME type: image/png)
File information
Structured data
Captions
Summary
[edit]DescriptionAn overview of epithelial–mesenchymal plasticity causes and consequences.png | Figure 1. An overview of epithelial–mesenchymal plasticity causes and consequences. Multiple signaling pathways such as TGF-𝛽, HIF-1𝛼 and Notch have been implicated in driving epithelial–mesenchymal transition (EMT). All these pathways tend to converge to a core regulatory circuit which includes two EMT-inducing transcription factors (EMT-TFs), SNAIL and ZEB, and two microRNAs, miR-34 and miR-200. The core regulatory circuit exhibits multi-stable dynamics: multiple stable steady states for the same level of EMT-inducing signal. These stable steady states contain different levels of SNAIL/ZEB/miR-34/miR-200 and thus corresponding to different EMT-associated phenotypes. The multi-stable dynamics of the core regulatory circuit allow for transitions among different stable states which leads to epithelial–mesenchymal plasticity. Cancer epithelial–mesenchymal plasticity typically enhances metastasis, allowing for disparate forms of migration and dissemination. In addition, epithelial–mesenchymal plasticity has been implicated in the acquisition of stem cell-like properties and immune evasion. |
Date | |
Source | https://www.mdpi.com/2077-0383/8/5/725 Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response. J. Clin. Med. 2019, 8, 725. https://doi.org/10.3390/jcm8050725 |
Author | Jia, D.; Li, X.; Bocci, F.; Tripathi, S.; Deng, Y.; Jolly, M.K.; Onuchic, J.N.; Levine, H. |
This file, which was originally posted to
https://www.mdpi.com/2077-0383/8/5/725 Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response. J. Clin. Med. 2019, 8, 725. https://doi.org/10.3390/jcm8050725, was reviewed on 13 October 2024 by reviewer Metacladistics, who confirmed that it was available there under the stated license on that date.
|
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Licensing
[edit]This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 22:42, 29 May 2024 | 2,790 × 2,059 (913 KB) | Rasbak (talk | contribs) | {{Information |description= Figure 1. An overview of epithelial–mesenchymal plasticity causes and consequences. Multiple signaling pathways such as TGF-𝛽, HIF-1𝛼 and Notch have been implicated in driving epithelial–mesenchymal transition (EMT). All these pathways tend to converge to a core regulatory circuit which includes two EMT-inducing transcription factors (EMT-TFs), SNAIL and ZEB, and two microRNAs, miR-34 and miR-200. The core regulatory circuit exhibits multi-stable dynamics: multiple... |
You cannot overwrite this file.
File usage on Commons
There are no pages that use this file.